*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T45615A - Adverse effect of thrombolytic drugs, initial encounter - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 6.84 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 061: ACUTE ISCHEMIC STROKE WITH USE OF THROMBOLYTIC AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 062: ACUTE ISCHEMIC STROKE WITH USE OF THROMBOLYTIC AGENT WITH COMPLICATION OR COMORBIDITY (CC) | DRG 023: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR CHEMOTHERAPY IMPLANT | DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 15,973 | ||||
| Total Hospitalizations with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 1,434 | ||||
| DRG Share of Total Hospitalizations | 0.05 | ||||
| % of Total ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter in DRG | 32.55 | ||||
| Avg LOS at DRG | 6.25 | ||||
| Avg LOS with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 5.9 | ||||
| Readmission Rate at DRG | 37.82 | ||||
| Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 37.31 | ||||
| Unplanned Readmission Rate at DRG | 9.3 | ||||
| Unplanned Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 6.06 | ||||
| Total Medicare payments at DRG | $293,483,130 | ||||
| Total Medicare payments with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $25,863,056 | ||||
| Total Medicare payment per Day at DRG | $2,940 | ||||
| Total Medicare payment per Day with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $3,056 | ||||
| Total Medicare payment per Hospitalization at DRG | $18,374 | ||||
| Total Medicare payment per Hospitalization with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $18,036 | ||||
| Total Medicare Charges at DRG | $1,663,575,489 | ||||
| Total Medicare Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $146,353,368 | ||||
| Avg Charges at DRG | $104,149 | ||||
| Avg Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $102,060 | ||||
| Mortality Rate at DRG | 14.58 | ||||
| Mortality Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 19.67 | ||||
| SNF Discharge Rate at DRG | 23.23 | ||||
| SNF Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 18.41 | ||||
| Home Discharge Rate at DRG | 12.85 | ||||
| Home Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 11.65 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 063: ACUTE ISCHEMIC STROKE WITH USE OF THROMBOLYTIC AGENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 253: OTHER VASCULAR PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 80,433 | ||||
| Total Hospitalizations with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 67 | ||||
| DRG Share of Total Hospitalizations | 0.24 | ||||
| % of Total ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter in DRG | 1.52 | ||||
| Avg LOS at DRG | 5.24 | ||||
| Avg LOS with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 6.06 | ||||
| Readmission Rate at DRG | 20.23 | ||||
| Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| Unplanned Readmission Rate at DRG | 13.84 | ||||
| Unplanned Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| Total Medicare payments at DRG | $734,471,819 | ||||
| Total Medicare payments with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $756,614 | ||||
| Total Medicare payment per Day at DRG | $1,743 | ||||
| Total Medicare payment per Day with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $1,864 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,131 | ||||
| Total Medicare payment per Hospitalization with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $11,293 | ||||
| Total Medicare Charges at DRG | $3,786,674,716 | ||||
| Total Medicare Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $6,459,750 | ||||
| Avg Charges at DRG | $47,079 | ||||
| Avg Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $96,414 | ||||
| Mortality Rate at DRG | 3.47 | ||||
| Mortality Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 20.28 | ||||
| SNF Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 23.88 | ||||
| Home Discharge Rate at DRG | 42.82 | ||||
| Home Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 38.81 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | DRG 003: ECMO OR TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITH MAJOR O.R. PROCEDURE | DRG 040: PERIPHERAL, CRANIAL NERVE AND OTHER NERVOUS SYSTEM PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 270: OTHER MAJOR CARDIOVASCULAR PROCEDURES W MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 271: OTHER MAJOR CARDIOVASCULAR PROCEDURES W COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 181,637 | ||||
| Total Hospitalizations with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 54 | ||||
| DRG Share of Total Hospitalizations | 0.55 | ||||
| % of Total ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter in DRG | 1.23 | ||||
| Avg LOS at DRG | 7.0 | ||||
| Avg LOS with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 4.56 | ||||
| Readmission Rate at DRG | 32.53 | ||||
| Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| Unplanned Readmission Rate at DRG | 19.84 | ||||
| Unplanned Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| Total Medicare payments at DRG | $2,845,609,163 | ||||
| Total Medicare payments with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $849,668 | ||||
| Total Medicare payment per Day at DRG | $2,237 | ||||
| Total Medicare payment per Day with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $3,454 | ||||
| Total Medicare payment per Hospitalization at DRG | $15,666 | ||||
| Total Medicare payment per Hospitalization with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $15,735 | ||||
| Total Medicare Charges at DRG | $14,794,146,746 | ||||
| Total Medicare Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $5,282,662 | ||||
| Avg Charges at DRG | $81,449 | ||||
| Avg Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $97,827 | ||||
| Mortality Rate at DRG | 25.14 | ||||
| Mortality Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 48.15 | ||||
| SNF Discharge Rate at DRG | 19.06 | ||||
| SNF Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| Home Discharge Rate at DRG | 20.69 | ||||
| Home Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 004: TRACHEOSTOMY WITH MV >96 HOURS OR PDX EXCEPT FACE, MOUTH AND NECK WITHOUT MAJOR O.R. PROCEDURE | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 069: TRANSIENT ISCHEMIA | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 024: CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PDX WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,478 | ||||
| Total Hospitalizations with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 42 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter in DRG | 0.95 | ||||
| Avg LOS at DRG | 25.29 | ||||
| Avg LOS with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 19.33 | ||||
| Readmission Rate at DRG | 74.5 | ||||
| Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | 85.71 | ||||
| Unplanned Readmission Rate at DRG | 8.79 | ||||
| Unplanned Readmission Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| Total Medicare payments at DRG | $3,386,848,549 | ||||
| Total Medicare payments with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $3,075,833 | ||||
| Total Medicare payment per Day at DRG | $2,945 | ||||
| Total Medicare payment per Day with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $3,788 | ||||
| Total Medicare payment per Hospitalization at DRG | $74,472 | ||||
| Total Medicare payment per Hospitalization with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $73,234 | ||||
| Total Medicare Charges at DRG | $15,882,518,852 | ||||
| Total Medicare Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $14,309,580 | ||||
| Avg Charges at DRG | $349,235 | ||||
| Avg Charges with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | $340,704 | ||||
| Mortality Rate at DRG | 13.7 | ||||
| Mortality Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 17.77 | ||||
| SNF Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA | ||||
| Home Discharge Rate at DRG | 1.95 | ||||
| Home Discharge Rate with ICD T45615A - Adverse effect of thrombolytic drugs, initial encounter | NA |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 43 |
| MAINE MEDICAL CENTER | 22 BRAMHALL ST | PORTLAND | ME | 04102 | 33 |
| MEMORIAL HERMANN TEXAS MEDICAL CENTER | 6411 FANNIN ST | HOUSTON | TX | 77030 | 30 |